A catalytic reaction of H2O2 production by an amyloid beta-peptide (Abeta)-Cu complex with cholesterol incorporated in a liposome was kinetically analyzed. The Michaelis-Menten model was applied to the H2O2 production reaction using cholesterol as the substrate catalyzed by the Abeta-Cu complex. The Km value for the Abeta-Cu complex catalytic reaction with cholesterol-containing 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) liposomes (Km=0.436 microM for Abeta(1-40); Km=0.641 microM for Abeta(1-42)) was found to be smaller than that with cholesterol-containing 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) liposomes (Km=0.585 microM for Abeta(1-40), Km=0.890 microM for Abeta(1-42)). The results imply that membrane properties could play an important role in the interactions of the Abeta-Cu complex with cholesterol in these liposomes. Considering the physical states of the cholesterol/POPC (liquid disordered phase) and cholesterol/DPPC (liquid ordered phase) liposomes in the present reaction conditions, the data obtained suggests that the H2O2-generating activity of the Abeta-Cu complex, accompanied by oxidation of membrane-incorporated cholesterol, could be effected by the phase of the liposome membranes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1263/jbb.100.455 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Multifunctional selenium-doped carbon dots for modulating Alzheimer's disease related toxic ions, inhibiting amyloid aggregation and scavenging reactive oxygen species.
Int J Biol Macromol
December 2024
Department of Chemistry, School of Chemistry and Chemical Engineering, Northwestern Polytechnical University, 127 Youyi Road, Xi'an 710072, China. Electronic address:
Article Synopsis
- β-Amyloid deposition, oxidative stress, and metal ion imbalance are key features of Alzheimer's disease, creating a need for effective multi-target therapies.
- Researchers developed multifunctional selenium-doped carbonized polymer dots (SeCDs) to inhibit Aβ aggregation, reduce reactive oxygen species (ROS), and chelate copper ions.
- SeCDs successfully clear harmful radicals and bind Cu ions, lowering cytotoxicity related to Aβ-Cu complexes, and show promise as a treatment option by reducing intracellular ROS levels.
Multifunctional porphyrin-substituted phenylalanine-phenylalanine nanoparticles for diagnostic and therapeutic applications in Alzheimer's disease.
Bioorg Chem
January 2025
Henan Province Key Laboratory of New Opto-electronic Functional Materials, Anyang Normal University, Anyang, Henan 455000, China. Electronic address:
β-Amyloid (Aβ) peptides are believed as the diagnostic biomarkers and therapeutic targets of Alzheimer's disease (AD). Their complexes with copper ions can catalyze the generation of reactive oxygen species (ROS) to further promote neuronal death. Herein, we suggested that porphyrin-substituted phenylalanine-phenylalanine nanoparticles (TPP-FF NPs) could inhibit the aggregation of Aβ monomers, disassemble the fibrillar Aβ aggregates under light illumination, and depressing the Cu-induced generation of ROS.
View Article and Find Full Text PDFAssociation of Basal Forebrain Atrophy With Cognitive Decline in Early Alzheimer Disease.
Neurology
July 2024
From the The Australian e-Health Research Centre (Y.X., V.D., J.F., P.B.), CSIRO Health and Biosecurity, Brisbane; Department of Nuclear Medicine and Centre for PET (V.D., C.R.), Austin Health, Melbourne; Centre for Precision Health (S.M.L.), Edith Cowan University; Collaborative Genomics and Translation Group (S.M.L.), School of Medical and Health Sciences, Edith Cowan University, Joondalup; Curtin Medical School (S.M.L.), Curtin University, Bentley; The Florey Institute of Neuroscience and Mental Health (C.J.F., C.R., C.L.M., P.M.), The University of Melbourne; Centre for Healthy Ageing (S.R.R.-S.), Health Futures Institute, Murdoch University; Australian Alzheimer's Research Foundation (S.R.R.-S., R.N.M.), Sarich Neuroscience Research Institute, Nedlands; School of Psychological Science (S.R.R.-S.), University of Western Australia, Crawley; School of Medical and Health Sciences (S.R.R.-S., R.N.M.), Edith Cowan University, Joondalup; Department of Biomedical Sciences (R.N.M.), Macquarie University, Sydney; Queensland Brain Institute (E.J.C.), and School of Biomedical Sciences (E.J.C.), The University of Queensland, Brisbane; and Cogstate Ltd. (P.M.), Melbourne, Australia.
Article Synopsis
- The study investigates how β-amyloid (Aβ) buildup in early Alzheimer’s disease (AD) relates to brain atrophy and cognitive decline, particularly in memory and attention.
- Participants were analyzed over a median of 6.1 years, revealing that those with Aβ present (both cognitively unimpaired and with mild cognitive impairment) experienced faster brain volume loss and cognitive decline compared to cognitively unimpaired Aβ-negative participants.
- Results indicate that atrophy in key brain regions, including the basal forebrain and hippocampus, mediates the relationship between Aβ levels and declining cognitive functions, highlighting the hippocampus's significant role in memory decline.
Power of Dopamine: Multifunctional Compound Assisted Conversion of the Most Risk Factor into Therapeutics of Alzheimer's Disease.
ACS Chem Neurosci
July 2024
Organic and Medicinal Chemistry and Structural Biology and Bioinformatics Division, CSIR─Indian Institute of Chemical Biology, 4, Raja S. C. Mullick Road, Jadavpur, Kolkata 700 032, WB, India.
Article Synopsis
- - In Alzheimer's disease, copper ions play a critical role by facilitating the production of harmful reactive oxygen species (ROS) when they combine with amyloid-β (Aβ) aggregates, promoting the disease's progression.
- - Researchers have developed Schiff base derivatives that act as copper chelators, targeting the Aβ-Cu complexes to prevent them from causing amyloid aggregation and reducing ROS generation.
- - The novel Schiff base compounds utilize dopamine's properties to both scavenge ROS and chelate copper ions, making them promising candidates for future Alzheimer's disease therapies.
Vanillin Benzothiazole Derivative Reduces Cellular Reactive Oxygen Species and Detects Amyloid Fibrillar Aggregates in Alzheimer's Disease Brain.
ACS Chem Neurosci
February 2023
Organic and Medicinal Chemistry and Structural Biology and Bioinformatics Division, CSIR-Indian Institute of Chemical Biology, 4, Raja S. C. Mullick Road, Jadavpur, Kolkata 700 032, WB, India.
The misfolding of amyloid beta (Aβ) peptides into Aβ fibrillary aggregates is a major hallmark of Alzheimer's disease (AD), which responsible for the excess production of hydrogen peroxide (HO), a prominent reactive oxygen species (ROS) from the molecular oxygen (O) by the reduction of the Aβ-Cu(I) complex. The excessive production of HO causes oxidative stress and inflammation in the AD brain. Here, we have designed and developed a dual functionalized molecule VBD by using π-conjugation (C═C) in the backbone structure.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!